Arrotex Pharmaceuticals
Drug Stores & Pharmacies · Australia · 201-500 Employees
View Company Info for Free
Overview
Headquarters
16 Giffnock Ave, Macquarie Park, New Sou...Website
www.arrotex.com.auRevenue
$92 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
2
2
About Arrotex Pharmaceuticals
Arrotex Pharmaceuticals is Australia's largest and most diversified pharmaceutical provider, offering a wide range of prescription medicines, biologics, and biosimilars. The company is dedicated to providing affordable access to trusted medicines and innovative solutions that enhance the quality of life for patients, pharmacists, and prescribers. With over 350 prescription medicines and a strong partnership network, Arrotex serves as a strategic partner for multinational pharmaceutical companies. Their commitment to investing in Australia's healthcare ecosystem positions them as a leading provider of hospital medicines and a key player in the pharmaceutical market.Explore more
Popular SearchesArrotex Pharmaceuticals Pty LtdArrotex PharmaceuticalsSIC Code 51,512NAICS Code 42,424Show moreArrotex Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arrotex Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Arrotex Pharmaceuticals has new funding data
Check out if Arrotex Pharmaceuticals is spiking on competitors!
Check if Arrotex Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Arrotex Pharmaceuticals
Earning: See what the market has to say on Arrotex Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Arrotex Pharmaceuticals launches new products
Click to see if Arrotex Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Arrotex Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Arrotex Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Arrotex Pharmaceuticals
Compare insights from companies similar to Arrotex Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arrotex Pharmaceuticals is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Arrotex Pharmaceuticals is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Arrotex Pharmaceuticals.
Arrotex Pharmaceuticals Tech Stack
A closer look at the technologies used by Arrotex Pharmaceuticals
See more technologies
Arrotex Pharmaceuticals News & Media
George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement
London, UK, 16 March 2026 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing and supply agreement with Arrotex Pharmaceuticals (“Arrotex”), a leading Australian pharmaceutical company and Australia’s largest supplier of medicines by prescription volume, granting Arrotex exclusive rights to seek regulatory approval of, and to commercialize, GMRx2 in Australia.Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Feb. 23, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol...Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Feb. 23, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), an innovative topical eyedrop for the treatment of inflammation and pain following ocular surgery in Australia and New Zealand. Arrotex, 'Australia's Medicine
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Arrotex Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Arrotex Pharmaceuticals is Australia's largest and most diversified pharmaceutical provider, offering a wide range of prescription medicines, biologics, and biosimilars. The company is dedicated to providing affordable access to trusted medicines and innovative solutions that enhance the quality of life for patients, pharmacists, and prescribers. W... Read More
